Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBM9036 in moderate to severe dry eye
NCT04092907Phase 2Completed
- Sponsor
- Harbour BioMed
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of tanfanercept in dry eye disease (DED), sponsored by Harbour BioMed. Started Mar 2019; status: completed.
02
Drugs
tanfanercept
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04092907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04092907.